(Q46700887)

English

Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

Trypanosoma cruzi

0 references

Emilio Malchiodi

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

object named as

Pablo D Becker

3

0 references

author name string

Silvia I Cazorla

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

Fernanda M Frank

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

Ricardo S Corral

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

Carlos A Guzmán

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

language of work or name

0 references

publication date

22 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

26

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

16

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

1999-2009

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

Pathogenesis of Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Chagas' heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

"Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Parasite antigen-induced IFN-gamma and IL-4 production by cells from pathopermissive and pathoresistant strains of mice infected with Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Antibody-dependent cell cytotoxicity against Trypanosoma cruzi is only mediated by protective antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Detection of parasite DNA in Chagas' heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Chagas disease etiology: autoimmunity or parasite persistence?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Anomalous electrophoretic behaviour of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi in relation to its apparent molecular mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Chagas' disease: reactivity against homologous tissues induced by different strains of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Enzymatic markers of heart lesion in mice infected with Trypanosoma cruzi and submitted to benznidazole chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress towards interruption of transmission of Chagas disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.02.011

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18342408

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46700887&oldid=2127349852"